ALNYLAM PHARMACEUTICALS, INC. (ALNY)

SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 6, 2026

Verified against EDGAR
Total Assets
$5.56B
Stockholders' Equity
$1.35B
Cash & Equivalents
$1.71B
Long-Term Debt
—

as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Jun 30, 2026, ALNYLAM PHARMACEUTICALS, INC. reported revenue of $1.29B, net income of $164.5M, and total assets of $5.56B. Every figure below is taken directly from ALNYLAM PHARMACEUTICALS, INC.'s SEC filings: each links to the source document on EDGAR.

Revenue trend

Revenue · FY2016–FY2025 · as reported

$3.71B$1.29B-$1.13B
FY2016FY2019FY2022FY2025
Revenue$3.71BNet income$313.7M
FY2016 revenue
$47.2M
FY2025 revenue
$3.71B

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025$3.71B$313.7M
FY2024$2.25B-$278.2M
FY2023$1.83B-$440.2M
FY2022$1.04B-$1.13B
FY2021$844.3M-$852.8M
FY2020$492.9M-$858.3M
FY2019$219.8M-$886.1M
FY2018$74.9M-$761.5M
FY2017$89.9M-$490.9M
FY2016$47.2M-$410.1M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KOct 29, 2026on EDGAR ↗
8-KJul 30, 2026on EDGAR ↗
10-QJul 30, 2026on EDGAR ↗
8-KMay 27, 2026on EDGAR ↗
10-QApr 30, 2026on EDGAR ↗
8-KApr 30, 2026on EDGAR ↗
DEF 14AApr 6, 2026on EDGAR ↗
8-KMar 4, 2026on EDGAR ↗
8-KFeb 12, 2026on EDGAR ↗
10-KFeb 12, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-Q

Total Assets$5.56Bsource ↗
Stockholders’ Equity$1.35Bsource ↗
Cash & Equivalents$1.71Bsource ↗
Long-Term Debt—source ↗

Income Statement

10-Q (quarterly) · period ended Jun 30, 2026

Revenue$1.29Bsource ↗
Net Income$164.5Msource ↗
Operating Income$231.4Msource ↗
Gross Profit$992.7Msource ↗
Cost of Revenue$298.3Msource ↗
R&D Expense$413.1Msource ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Jun 30, 2026

EPS (diluted)$1.21source ↗
EPS (basic)$1.23source ↗
Shares Outstanding133.8Msource ↗
Cash from Operations—source ↗
Cash from Financing—source ↗
Cash from Investing—source ↗

Insider activity

Form 4 open-market activity, last 180 days

Buys
0
Sells
6
Net shares
-5.6K

Restatement history

Point-in-time

2 of 427 annual fact-keys were materially restated between filings: what ALNYLAM PHARMACEUTICALS, INC. first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.

See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.

Deeper fundamentals

A free API key reaches ALNY’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/ALNY

MCP tool: get_sec_fundamentals ticker=ALNY

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/ALNY/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=ALNY as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/ALNY/history

MCP tool: get_fundamentals_history ticker=ALNY

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/ALNY

MCP tool: get_financial_health ticker=ALNY

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.